Auro Laboratories Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Sharat Deorah

İcra Kurulu Başkanı

₹5.3m

Toplam tazminat

CEO maaş yüzdesi	100.0%
CEO görev süresi	35.5yrs
CEO sahipliği	22.4%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	6.6yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Sharat Deorah'un ücretlendirmesi Auro Laboratories'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	₹62m
Jun 30 2024	n/a	n/a	₹78m
Mar 31 2024	₹5m	₹5m	₹78m
Dec 31 2023	n/a	n/a	₹72m
Sep 30 2023	n/a	n/a	₹48m
Jun 30 2023	n/a	n/a	₹31m
Mar 31 2023	₹4m	₹4m	₹24m
Dec 31 2022	n/a	n/a	₹11m
Sep 30 2022	n/a	n/a	₹14m
Jun 30 2022	n/a	n/a	₹19m
Mar 31 2022	₹12m	₹12m	₹28m
Dec 31 2021	n/a	n/a	₹39m
Sep 30 2021	n/a	n/a	₹53m
Jun 30 2021	n/a	n/a	₹69m
Mar 31 2021	₹12m	₹12m	₹72m
Dec 31 2020	n/a	n/a	₹61m
Sep 30 2020	₹6m	₹6m	₹51m
Jun 30 2020	n/a	n/a	₹43m
Mar 31 2020	n/a	n/a	₹41m
Dec 31 2019	n/a	n/a	₹52m
Sep 30 2019	n/a	n/a	₹55m
Jun 30 2019	n/a	n/a	₹49m
Mar 31 2019	₹6m	₹6m	₹44m
Dec 31 2018	n/a	n/a	₹37m
Sep 30 2018	n/a	n/a	₹36m
Jun 30 2018	n/a	n/a	₹37m
Mar 31 2018	₹5m	₹5m	₹35m

Tazminat ve Piyasa: Sharat 'nin toplam tazminatı ($USD 62.29K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 42.63K ).

Tazminat ve Kazançlar: Sharat 'in maaşı son bir yılda %20'den fazla arttı.

CEO

Sharat Deorah (74 yo)

35.5yrs

Görev süresi

₹5,250,000

Tazminat

Mr. Sharat Sahadeolal Deorah, B.Com. serves as the Managing Director and Executive Chairman of the Board at Auro Laboratories Limited. He serves as Director since May 26, 1989 at Auro Laboratories Limited....

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sharat Deorah	Executive Chairman & MD	35.5yrs	₹5.25m	22.38% ₹ 278.4m
Siddhartha Deorah	Whole Time Director	25.3yrs	₹5.25m	7.15% ₹ 88.9m
Kiran Kulkarni	Additional Whole Time Director	3.5yrs	₹2.25m	0.00016% ₹ 2.0k
Kavita Sharma	Non-Executive Independent Director	9.7yrs	₹11.00k	Veri yok
Vishal Jhunjhunwala	Non-Executive Independent Director	1.3yrs	₹6.00k	Veri yok
Mahendra Daga	Additional Non-Executive Independent Director	less than a year	Veri yok	Veri yok

6.6yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 530233 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.6 yıldır).

Auro Laboratories Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Auro Laboratories Limited Announces Resignation of Sweta Agarwal as Company Secretary and Compliance Officer, Effective July 30, 2024

Less than half of directors are independent

Auro Laboratories Limited Appoints Shaan Jain as Chief Financial Officer

Auro Laboratories Limited Announces the Resignation of Amit Mahipat Shah as Chief Financial Officer, Effective October 1, 2023

Auro Laboratories Limited Appoints Vishal Kailashchandra Jhunjhunwala as an Non-Executive & Independent Director

Less than half of directors are independent

Recent updates

Investor sentiment deteriorates as stock falls 22%

Now 25% undervalued

Second quarter 2025 earnings released: EPS: ₹0.57 (vs ₹3.16 in 2Q 2024)

Auro Laboratories Limited to Report Q2, 2025 Results on Nov 11, 2024

Investor sentiment improves as stock rises 19%

First quarter 2025 earnings released: EPS: ₹1.21 (vs ₹1.14 in 1Q 2024)

Auro Laboratories Limited to Report Q1, 2025 Results on Aug 09, 2024

Auro Laboratories Limited Announces Resignation of Sweta Agarwal as Company Secretary and Compliance Officer, Effective July 30, 2024

Investor sentiment deteriorates as stock falls 17%

Full year 2024 earnings released: EPS: ₹12.50 (vs ₹3.92 in FY 2023)

Auro Laboratories Limited to Report Q4, 2024 Results on May 25, 2024

Investor sentiment improves as stock rises 26%

Less than half of directors are independent

Investor sentiment improves as stock rises 15%

Third quarter 2024 earnings released: EPS: ₹4.39 (vs ₹0.59 in 3Q 2023)

Auro Laboratories Limited to Report Q3, 2024 Results on Feb 06, 2024

Investor sentiment improves as stock rises 21%

Auro Laboratories Limited Appoints Shaan Jain as Chief Financial Officer

Investor sentiment improves as stock rises 23%

Second quarter 2024 earnings released: EPS: ₹3.16 (vs ₹0.34 in 2Q 2023)

Auro Laboratories Limited to Report Q2, 2024 Results on Nov 09, 2023

Auro Laboratories Limited Announces the Resignation of Amit Mahipat Shah as Chief Financial Officer, Effective October 1, 2023

Auro Laboratories Limited Appoints Vishal Kailashchandra Jhunjhunwala as an Non-Executive & Independent Director

Less than half of directors are independent

Auro Laboratories Limited, Annual General Meeting, Sep 23, 2023

Auro Laboratories Limited Announces Resignation of Govardhan Das Agarwal as Director

First quarter 2024 earnings released: EPS: ₹1.14 (vs ₹0.13 in 1Q 2023)

Auro Laboratories Limited to Report Q1, 2024 Results on Jul 31, 2023

Full year 2023 earnings released: EPS: ₹3.92 (vs ₹4.56 in FY 2022)

Investor sentiment improves as stock rises 23%

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: ₹0.59 (vs ₹0.98 in 3Q 2022)

Auro Laboratories Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: EPS: ₹0.34 (vs ₹1.14 in 2Q 2022)

Auro Laboratories Limited to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: ₹0.13 (vs ₹1.71 in 1Q 2022)

Auro Laboratories Limited to Report Q1, 2023 Results on Aug 02, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹4.56 (vs ₹11.52 in FY 2021)

Auro Laboratories Limited Announces Management Changes

Auro Laboratories Limited to Report Q4, 2022 Results on May 30, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Whole Time Director recently bought ₹86k worth of stock

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS ₹1.71 (vs ₹2.22 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹11.52 (vs ₹6.51 in FY 2020)

Investor sentiment improved over the past week

Auro Laboratories Limited Appoints Mrs. Kavita Sharma as Independent Director

Auro Laboratories Limited to Report Q3, 2021 Results on Feb 11, 2021

Investor sentiment improved over the past week

New 90-day high: ₹98.80

Second quarter 2021 earnings released: EPS ₹3.62

Market bids up stock over the past week

Auro Laboratories Limited to Report Q2, 2020 Results on Nov 05, 2020

New 90-day high: ₹67.65

New 90-day high - ₹58.10

First quarter earnings released

Auro Laboratories Limited to Report Q1, 2021 Results on Aug 31, 2020

New 90-day high - ₹52.25

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş